GlassScriptPhysician profile
Amy B Heeringa
NPI 1427291707
$857.72
in general payments reported to CMS, 2019-2025
11 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.57 · 2020: $11.24 · 2021: $16.57 · 2022: $80.83 · 2023: $241 · 2024: $348 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.52 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $295.54 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $280.66 | 2022-2024 | Acessa Provu System |
| Medtronic, INC. | $56.27 | 2022 | |
| Biogen, INC. | $51.80 | 2024-2025 | Zurzuvae |
| Minerva Surgical, INC | $47.38 | 2019-2021 | |
| Applied Medical Resources Corporation | $28.31 | 2023 | |
| Sage Therapeutics, LLC | $27.21 | 2024 | |
| Lsi Solutions INC | $20.17 | 2024 | Fornisee |
| Exeltis, USA INC. | $17.93 | 2024 | Slynd |
| Millicent US INC | $17.23 | 2025 | Femring, Intrarosa |
| Gynesonics, INC. | $15.22 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Heeringa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.